1188301-89-4Relevant articles and documents
RAF KINASE INHIBITORS
-
Paragraph 00200-00201, (2014/11/11)
Described herein are compounds, pharmaceutical compositions and methods for the inhibition of RAF kinae mediated signaling. Said compounds, pharmaceutical compositions and methods have utility in the treatment of human disease and disorders.
NOVEL HETEROCYCLIC COMPOUNDS AND USES THEROF
-
Page/Page column 112, (2009/10/22)
New substituted heterocyclic compounds, compositions containing them, and methods of using them for the inhibition of Raf kinase activity are provided. The new compounds and compositions may be used either alone or in combination with at least one additional agent for the treatment of a Raf kinase mediated disorder, such as cancer.